Routine inducement grant with no trading signal. Monitor upcoming clinical milestones for ATR 1072 (IND cleared) and ATR 1086 for potential pipeline catalysts.
Price Chart
Executive Summary
Atrium Therapeutics granted inducement stock options and restricted stock units to a new non-executive employee under its 2026 Inducement Plan. The awards are routine and immaterial to the company's financials or operations.
Key Facts
- Inducement grants awarded on October 20, 2026 to one non-executive new hire.
- Non-qualified stock options to purchase 9,500 shares at $7.98 per share.
- Restricted stock units for 4,750 shares granted.
- Awards vest over time subject to continued service; no immediate dilution.
- Grants approved by independent directors under Nasdaq Listing Rule 5635(c)(4).
Financial Impact
Immaterial — 14,250 total shares (options + RSUs) represent a negligible fraction of outstanding shares.
Risk Factors
- No material financial or operational risk from this grant.
Investment Themes
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-prn-302914657 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 20, 2026 6d ago | Press Release | $8.00 | awaiting T+5 | — | $8.05 (+0.63%) |
Oct 9, 2026 17d ago | 8-K/A | $8.40 $7.67 | ▼ −8.69% | ▼ −6.72% | $8.05 (−4.17%) |
Oct 8, 2026 18d ago | 8-K | $8.26 $7.82 | ▲ +5.33% | ▲ +5.05% | $8.05 (+2.54%) |
Sep 21, 2026 5w ago | Press Release | $9.22 $8.42 | ▼ −8.68% | ▼ −7.49% | $8.05 (−12.69%) |
Aug 20, 2026 9w ago | Press Release | $13.20 $13.64 | ▲ +3.33% | ▲ +2.86% | $8.05 (−39.02%) |
Aug 13, 2026 10w ago | 8-K | $12.84 $13.20 | ▲ +2.80% | ▲ +4.17% | $8.05 (−37.31%) |
Aug 13, 2026 10w ago | Press Release | $12.84 $13.20 | ▲ +2.80% | ▲ +4.17% | $8.05 (−37.31%) |
Jul 20, 2026 14w ago | Press Release | $12.29 $11.57 | ▼ −5.86% | ▼ −4.63% | $8.05 (−34.50%) |
Jul 14, 2026 14w ago | 8-K | $12.30 $12.17 | ▼ −1.06% | ▼ −0.08% | $8.05 (−34.55%) |
May 14, 2026 23w ago | 8-K | $13.23 $13.09 | ▼ −1.06% | ▼ −2.02% | $8.05 (−39.15%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers